|
1
|
Vallières E, Shepherd FA, Crowley J, et
al: International Association for the Study of Lung Cancer
International Staging Committee and Participating Institutions: The
IASLC Lung Cancer Staging Project: Proposals regarding the
relevance of TNM in the pathologic staging of small cell lung
cancer in the forthcoming (seventh) edition of the TNM
classification for lung cancer. J Thorac Oncol. 4:1049–1059. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rivera MP, Mehta AC and Wahidi MM:
Establishing the diagnosis of lung cancer: Diagnosis and management
of lung cancer, 3rd ed: American College of Chest Physicians
evidence-based clinical practice guidelines. Chest. 143(Suppl 5):
eS142–S65. 2013. View Article : Google Scholar
|
|
3
|
Noda K, Nishiwaki Y, Kawahara M, et al:
Japan Clinical Oncology Group: Irinotecan plus cisplatin compared
with etoposide plus cisplatin for extensive small-cell lung cancer.
N Engl J Med. 346:85–91. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chute JP, Chen T, Feigal E, Simon R and
Johnson BE: Twenty years of phase III trials for patients with
extensive-stage small-cell lung cancer: Perceptible progress. J
Clin Oncol. 17:1794–1801. 1999.PubMed/NCBI
|
|
5
|
Ross JS, Wang K, Elkadi OR, Tarasen A,
Foulke L, Sheehan CE, Otto GA, Palmer G, Yelensky R, Lipson D, et
al: Next-generation sequencing reveals frequent consistent genomic
alterations in small cell undifferentiated lung cancer. J Clin
Pathol. 67:772–776. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van Kessel CS, Samim M, Koopman M, van den
Bosch MA, Rinkes Borel IH, Punt CJ and van Hillegersberg R:
Radiological heterogeneity in response to chemotherapy is
associated with poor survival in patients with colorectal liver
metastases. Eur J Cancer. 49:2486–2493. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Win T, Miles KA, Janes SM, Ganeshan B,
Shastry M, Endozo R, Meagher M, Shortman RI, Wan S, Kayani I, et
al: Tumor heterogeneity and permeability as measured on the CT
component of PET/CT predict survival in patients with non-small
cell lung cancer. Clin Cancer Res. 19:3591–3599. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gerlinger M, Rowan AJ, Horswell S, et al:
Intratumor heterogeneity and branched evolution revealed by
multiregion sequencing. N Engl J Med. 366:883–892. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen ZY, Zhong WZ, Zhang XC, Su J, Yang
XN, Chen ZH, Yang JJ, Zhou Q, Yan HH, An SJ, et al: EGFR mutation
heterogeneity and the mixed response to EGFR tyrosine kinase
inhibitors of lung adenocarcinomas. Oncologist. 17:978–985. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oken MM, Creech RH, Tormey DC, et al:
Toxicity and response criteria of the Eastern Cooperative Oncology
Group. Am J Clin Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shepherd FA, Crowley J, Van Houtte P,
Postmus PE, Carney D, Chansky K, Shaikh Z and Goldstraw P:
International Association for the Study of Lung Cancer
International Staging Committee and Participating Institutions: The
International Association for the Study of Lung Cancer lung cancer
staging project: Proposals regarding the clinical staging of small
cell lung cancer in the forthcoming (seventh) edition of the tumor
node, metastasis classification for lung cancer. J Thorac Oncol.
2:1067–1077. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu CY, Hu HY, Pu CY, Huang N, Shen HC, Li
CP and Chou YJ: Aerodigestive tract, lung and haematological
cancers are risk factors for tuberculosis: An 8-year
population-based study. Int J Tuberc Lung Dis. 15:125–130.
2011.PubMed/NCBI
|
|
13
|
Kim HR, Hwang SS, Ro YK, Jeon CH, Ha DY,
Park SJ, Lee CH, Lee SM, Yoo CG, Kim YW, et al: Solid-organ
malignancy as a risk factor for tuberculosis. Respirology.
13:413–419. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nair R, Prabhash K, Sengar M, Bakshi A,
Gujral S, Gupta S and Parikh P: The effect of short-term intensive
chemotherapy on reactivation of tuberculosis. Ann Oncol.
18:1243–1245. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stratton JA, Byfield PE, Byfield JE, Small
RC, Benfield J and Pilch Y: A comparison of the acute effects of
radiation therapy, including or excluding the thymus, on the
lymphocyte subpopulations of cancer patients. J Clin Invest.
56:88–97. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zack MB, Stottmeier K, Berg G and Kazemi
H: The effect of radiation on microbiologic characteristics of M
tuberculosis. Chest. 66:240–243. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim DK, Lee SW, Yoo CG, Kim YW, Han SK,
Shim YS and Yim JJ: Clinical characteristics and treatment
responses of tuberculosis in patients with malignancy receiving
anticancer chemotherapy. Chest. 128:2218–2222. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuo CH, Lo CY, Chung FT, Lee KY, Lin SM,
Wang CH, Heh CC, Chen HC and Kuo HP: Concomitant active
tuberculosis prolongs survival in non-small cell lung cancer: A
study in a tuberculosis-endemic country. PLoS One. 7:e332262012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Edelman MJ, Chansky K, Gaspar LE, Leigh B,
Weiss GR, Taylor SA, Crowley J, Livingston R and Gandara DR: Phase
II trial of cisplatin/etoposide and concurrent radiotherapy
followed by paclitaxel/carboplatin consolidation for limited
small-cell lung cancer: Southwest oncology group 9713. J Clin
Oncol. 22:127–132. 2004. View Article : Google Scholar : PubMed/NCBI
|
